Skip to main content
neurologicalemerging evidence

Depression (Transcranial PBM)

Published: Last updated:

Source: Clinical Research (Emerging)

Transcranial PBM targeting the prefrontal cortex for treatment of depression. NIR light is applied to the forehead to reach the dorsolateral prefrontal cortex, an area implicated in depression and targeted by other neuromodulation therapies like TMS.

Protocol Parameters

ConditionMajor Depressive Disorder
Wavelengths810nm, 830nm
Dosage10-20 J/cm² transcranially
Irradiance50-100 mW/cm² at scalp
Duration10-20 minutes
Frequency2-3x per week for 8+ weeks
Body Zonehead
Evidence LevelEmerging

Mechanism of Action

Transcranial PBM to the prefrontal cortex enhances neuronal mitochondrial function, increases regional cerebral blood flow, and modulates prefrontal cortex activity. These effects may normalize the hypoactivation of the left dorsolateral prefrontal cortex observed in depression.

Key Studies

  • Schiffer et al. (2009) - PBM to the forehead for depression
  • Cassano et al. (2016) - Transcranial PBM for depression pilot study
  • Cassano et al. (2018) - Near-infrared transcranial PBM for depression RCT

Treatment Tips

  • *Target the left forehead primarily (left DLPFC)
  • *This is experimental and not a replacement for standard depression treatment
  • *Continue existing medications and therapy
  • *Track symptoms with PHQ-9 or similar validated instrument

Contraindications

  • !Suicidal ideation (seek immediate professional help)
  • !History of seizures
  • !Not a replacement for antidepressant medication or psychotherapy

Research Basis

This content is informed by 47+ published peer-reviewed studies on photobiomodulation.